大陆av三级片在线观看_国产三级女主播视频无毒_伊人激情网热门韩剧_国产高清最新在线看片_日本免费一二区在线电影_挺进亲女小蕾的嫩苞视频_亚洲中文字幕一区二区_开心综合亚洲_日韩明星性高潮视频免费观看_亚洲精品无码久久网

Technology platform
Innovation, technology, integration and sharing
Inhalation Preparation

The company took the lead in entering the field of inhalation preparation R&D in 2014, conducting literature research on inhalation preparation varieties with market potential, and establishing relevant standards and methods to analyze aerodynamic characteristics (such as fine particles, delivery rate and total delivery volume) and other atomization characteristics. ) indicators to ensure the establishment of a preparation quality evaluation system; at different stages of prescription screening, process research, pilot scale-up and industrialization, technical problems that arise will be solved in a targeted manner according to the different characteristics of the varieties, so that generics of inhaled preparations can be compared with The quality of the reference preparation is equivalent, and research and development of new peptide drugs for inhalation preparations are being carried out. The platform is equipped with complete inhalation characteristics research equipment such as multi-stage impactors, breathing simulators, and laser particle size analyzers; the technical team has a complete R&D system and has accumulated successful R&D experience in different types of atomized inhalation preparations in practice, and has completed The prescription process research and scale-up production of multiple inhalation preparations include albuterol sulfate solution for inhalation, compound ipratropium bromide solution for inhalation, ipratropium bromide solution for inhalation and other varieties have been approved.

You are welcome to contact us via the online form below.

We will answer your inquiries in various ways, and jointly provide customized professional consultation and solutions for your research and development needs.

What information and information do you want to know?
General consultation
Business consulting
Media and investment
Content of your inquiry
name
email
telphone
address
code